Gong, J.; Osipov, A.; Lorber, J.; Tighiouart, M.; Kwan, A.K.; Muranaka, H.; Akinsola, R.; Billet, S.; Levi, A.; Abbas, A.;
et al. Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol. Biomedicines 2023, 11, 1392.
https://doi.org/10.3390/biomedicines11051392
AMA Style
Gong J, Osipov A, Lorber J, Tighiouart M, Kwan AK, Muranaka H, Akinsola R, Billet S, Levi A, Abbas A,
et al. Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol. Biomedicines. 2023; 11(5):1392.
https://doi.org/10.3390/biomedicines11051392
Chicago/Turabian Style
Gong, Jun, Arsen Osipov, Jeremy Lorber, Mourad Tighiouart, Albert K. Kwan, Hayato Muranaka, Rasaq Akinsola, Sandrine Billet, Abrahm Levi, Anser Abbas,
and et al. 2023. "Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol" Biomedicines 11, no. 5: 1392.
https://doi.org/10.3390/biomedicines11051392
APA Style
Gong, J., Osipov, A., Lorber, J., Tighiouart, M., Kwan, A. K., Muranaka, H., Akinsola, R., Billet, S., Levi, A., Abbas, A., Davelaar, J., Bhowmick, N., & Hendifar, A. E.
(2023). Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol. Biomedicines, 11(5), 1392.
https://doi.org/10.3390/biomedicines11051392
